|
|
 |
|
Viewing report
|
|
|
|
Other OTC Healthcare Products Market in Egypt to 2014 (OTC Healthcare)
Datamonitor, Feb 2011, Pages: 28
Introduction
This databook provides key data and information on the Other OTC Healthcare Products Market in Egypt (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
-Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
-Category level company and brand share as well as distribution share information for 2007 and 2008
Highlights
Other OTC healthcare products category was valued at EGP410.5m ($75.6m) in 2009, representing a CAGR of 3% since 2004.
By the end of 2014, other OTC healthcare products category will be worth EGP464.3m ($85.5m), with an expected CAGR of 2.5% between 2009 and 2014.
Other OTC healthcare products market was led by rectal medications (representing 32.3% of the total value) followed by anti-smoking aids and motion sickness, with a 27.6% and 23.5% market share, respectively. Eye / ear drops and sleeping aids constitute the remaining segments with a 13.4% and 3.2% market share, respectively.
GlaxoSmithKline Plc is the market leader with a 21.4% share of the market.
Reasons to Purchase
-Develop business strategies by understanding the quantitative trends within the Other OTC Healthcare Products Market in Egypt (OTC Healthcare)
-Design effective marketing and sales strategies by identifying key market categories and segments
-Identify key players within the market to plan lucrative M&A, partnerships and agreements
|
|
|
|
